News ViiV Healthcare study reveals outdated perceptions of HIV New research from ViiV Healthcare has revealed a widespread gap in public knowledge and understanding of HIV worldwide, with
Views & Analysis A true story: Living with AIDS A 50-year-old man relates his personal experience of living with the condition.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
![iStock-497484764 [Converted]](https://pharmaphorum.com/wp-content/uploads/2016/11/world-aids-day-image.jpg)
